These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
673 related articles for article (PubMed ID: 20385637)
1. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts. Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637 [TBL] [Abstract][Full Text] [Related]
2. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data. Schneeweiss S; Patrick AR; Solomon DH; Mehta J; Dormuth C; Miller M; Lee JC; Wang PS Arch Gen Psychiatry; 2010 May; 67(5):497-506. PubMed ID: 20439831 [TBL] [Abstract][Full Text] [Related]
3. Newer generation antidepressants for depressive disorders in children and adolescents. Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227 [TBL] [Abstract][Full Text] [Related]
4. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents]. Bailly D Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514 [TBL] [Abstract][Full Text] [Related]
5. Antidepressants and the risk of suicidal behaviors. Jick H; Kaye JA; Jick SS JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848 [TBL] [Abstract][Full Text] [Related]
6. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)]. Hjalmarsson L; Corcos M; Jeammet P Encephale; 2005; 31(3):309-16. PubMed ID: 16142045 [TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents. Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776 [TBL] [Abstract][Full Text] [Related]
8. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438 [TBL] [Abstract][Full Text] [Related]
9. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Tanskanen A; Haukka J Arch Gen Psychiatry; 2006 Dec; 63(12):1358-67. PubMed ID: 17146010 [TBL] [Abstract][Full Text] [Related]
11. Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning. Bushnell GA; Stürmer T; Swanson SA; White A; Azrael D; Pate V; Miller M Psychiatr Serv; 2016 Mar; 67(3):302-9. PubMed ID: 26567938 [TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. Mandrioli R; Mercolini L; Saracino MA; Raggi MA Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078 [TBL] [Abstract][Full Text] [Related]
13. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step. Brent DA Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756 [No Abstract] [Full Text] [Related]
14. Antidepressants and suicide attempts in children. Cooper WO; Callahan ST; Shintani A; Fuchs DC; Shelton RC; Dudley JA; Graves AJ; Ray WA Pediatrics; 2014 Feb; 133(2):204-10. PubMed ID: 24394688 [TBL] [Abstract][Full Text] [Related]
15. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA. Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116 [TBL] [Abstract][Full Text] [Related]
17. FDA questions antidepressant safety for children. Oransky I Lancet; 2003 Nov; 362(9395):1558. PubMed ID: 14627000 [No Abstract] [Full Text] [Related]
18. Suicide prevention and serotonergic drugs. Montgomery SA Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249 [TBL] [Abstract][Full Text] [Related]
19. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects. Leon AC; Keller MB; Warshaw MG; Mueller TI; Solomon DA; Coryell W; Endicott J Am J Psychiatry; 1999 Feb; 156(2):195-201. PubMed ID: 9989554 [TBL] [Abstract][Full Text] [Related]
20. Relationship between antidepressants and suicide attempts: an analysis of the Veterans Health Administration data sets. Gibbons RD; Brown CH; Hur K; Marcus SM; Bhaumik DK; Mann JJ Am J Psychiatry; 2007 Jul; 164(7):1044-9. PubMed ID: 17606656 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]